UK REACH : Implementations and Implications

Time & Location

Thursday: 14.00 to 15.00, Stage 1

Guest panellist:

Dr. Andrew SmithHead of REACH-CLP-PIC Technical Delivery, and Toxicology, Ecotoxicology and Environmental Fate Chemicals Regulation Division - Health & Safety Executive

About this Session


UK REACH : Implementations and Implications

Running on both days, bringing together a daily balanced panel drawn from government/gov agency , industry, association, legal & NGO sources, the UK REACH panel will seek to address this hugely topical and sensitive issue for attending manufacturers, distributors as well as downstream formulator industries, pharma to automotive and other key chemical-user industry groups.

Each panel session provides an opportunity to hear contrasting perspectives from panellists around this key topic, seeking to address ‘real concerns’ from across the industry as well as reflecting day to day sector practicalities. Opening up then into an open Q&A , audience participants get the chance to get up to the minute latest feedback from expert industry panellists.

Panellists for THUR 16th Sept currently include:

  • Neil Hollis, Regulatory Affairs Mgr – BASF plc  (Panel Host)
  • Douglas Leech, Technical Director – Chemical Business Association (CBA)
  • Jane Lawson, Head of Global Product Safety and Regulatory Affairs – Croda
  • Simon Tilling, Partner – Burges Salmon
  • Chloe Alexander, Trade Campaigner – CHEM Trust
  • Jonathan Dale, Managing Scientist – Exponent
  • Andrew Smith, Regulatory Specialist – Health & Safety Executive

Check website for latest programme updates

Panellist bio:

Andrew has been Head of operational delivery for REACH, CLP and PIC in HSE’s Chemicals Regulatory Division since 2019. Teams in his Unit are also responsible for the toxicological and environmental assessment of biocides and plant protection products. In recent years, he has provided advice to industry and worked closely with officials from other government departments to ensure readiness for the UK’s exit from the EU. Previously, he contributed to the development of the EU REACH and CLP Regulations, and led the UK’s Competent Authority for REACH. Andrew joined HSE in 1992 as a toxicologist and has spent much of his career working closely with the European Chemicals Agency (ECHA) and similar international bodies on regulatory dossiers. He was one of the UK’s two scientific experts on ECHA’s Risk Assessment Committee, 2008-2019.

Main messages

HSE doesn’t have the lead policy role for UK REACH, so our focus is on providing a high quality regulatory service as the “Agency” that is driven by wider government and devolved policy, industry inputs, and the legislation itself. To achieve this we need to embed and operationalise efficient, effective processes and policies; recruit and train many new specialist staff, and work closely with partners in government, the scientific community, industry stakeholders and NGOs, as well as engaging internationally.  In the early years of UK REACH, we must both help ensure business continuity and initiate UK-specific regulatory activity to address key risks and substances of concern.